Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 13392-28-4
Drug Levels and Effects
Summary of Use during Lactation
No information is available on rimantadine during breastfeeding. The manufacturer states that the drug should not be used during breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Influenza) Oseltamivir, Zanamivir
Substance Identification
Substance Name
Rimantadine
CAS Registry Number
13392-28-4
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Amantadine.[Drugs and Lactation Database (...]Review Amantadine.. Drugs and Lactation Database (LactMed®). 2006
- Heterocyclic rimantadine analogues with antiviral activity.[Bioorg Med Chem. 2006]Heterocyclic rimantadine analogues with antiviral activity.Zoidis G, Fytas C, Papanastasiou I, Foscolos GB, Fytas G, Padalko E, De Clercq E, Naesens L, Neyts J, Kolocouris N. Bioorg Med Chem. 2006 May 15; 14(10):3341-8. Epub 2006 Jan 24.
- [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].[Vopr Virusol. 1980][Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].Pushkarskaia NL, L'vov ND, Galegov GA. Vopr Virusol. 1980 May-Jun; (3):303-6.
- Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.[Infect Immun. 1979]Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.Koff WC, Peavy DL, Knight V. Infect Immun. 1979 Mar; 23(3):665-9.
- Review Methazolamide.[Drugs and Lactation Database (...]Review Methazolamide.. Drugs and Lactation Database (LactMed®). 2006
- Rimantadine - Drugs and Lactation Database (LactMed®)Rimantadine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...